Table 3. B19V DNA and antibodies in plasma pools.
Blood products manufactures | Sample type |
Samples detection (n) |
B19V DNA-positive samples | |||||||
---|---|---|---|---|---|---|---|---|---|---|
B19 DNA positive (n) | Prevalence of B19 DNA (%) | 95% confidence interval [CI] | B19 viral load ≥1 ×10 4 IU/mL (n) | Prevalence of B19 viral load ≥1 ×10 4 IU/mL (%) | 95% confidence interval [CI] | IgG positive (%) | IgM positive (%) | |||
A | plasma pools | 100 | 27 | 27 | 18.15 ∼ 5.85 | 4 | 4 | 0 ∼ 6.40 | 100 | 0 |
B | plasma pools | 100 | 90 | 90 | 84.02 ∼ 95.98 | 21 | 21 | 12.88 ∼ 29.12 | 100 | 0 |
C | plasma pools | 100 | 81 | 81 | 73.18 ∼ 88.82 | 17 | 17 | 13.74 ∼ 30.26 | 100 | 0 |
D | plasma pools | 100 | 61 | 61 | 51.27 ∼ 70.73 | 29 | 29 | 19.95 ∼ 38.05 | 100 | 0 |
Total | plasma pools | 400 | 259 | 64.8 | 60.05 ∼ 69.45 | 71 | 17.8 | 14.91 ∼ 22.59 | 100 | 0 |